Search company, investor...

Combinent BioMedical Systems

Founded Year

2000

Stage

Dead | Dead

Total Raised

$6.61M

About Combinent BioMedical Systems

Combinent Biomedical Systems is a women's healthcare company focused on transvaginal delivery of drugs. The company's platform allows for the systemic delivery of large and small molecule drugs, the user-friendly delivery of combination therapies in a single intervention. Combinent is targeting women's reproductive endocrinology disorders initially. Follow-on applications include diabetes, obesity, and infectious disease.

Headquarters Location

420 Bedford Street Suite 240

Lexington, Massachusetts, 02420,

United States

781-761-1340

Missing: Combinent BioMedical Systems's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Combinent BioMedical Systems's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Combinent BioMedical Systems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Combinent BioMedical Systems is included in 3 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

1,482 items

Startups focused on providing products and services catering to women's health and wellbeing.

D

Diabetes

1,899 items

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Combinent BioMedical Systems Patents

Combinent BioMedical Systems has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/4/2013

Bacterial vaginosis, Drug delivery devices, Dosage forms, Antiandrogens, Hormonal antineoplastic drugs

Application

Application Date

12/4/2013

Grant Date

Title

Related Topics

Bacterial vaginosis, Drug delivery devices, Dosage forms, Antiandrogens, Hormonal antineoplastic drugs

Status

Application

Combinent BioMedical Systems Frequently Asked Questions (FAQ)

  • When was Combinent BioMedical Systems founded?

    Combinent BioMedical Systems was founded in 2000.

  • Where is Combinent BioMedical Systems's headquarters?

    Combinent BioMedical Systems's headquarters is located at 420 Bedford Street, Lexington.

  • What is Combinent BioMedical Systems's latest funding round?

    Combinent BioMedical Systems's latest funding round is Dead.

  • How much did Combinent BioMedical Systems raise?

    Combinent BioMedical Systems raised a total of $6.61M.

  • Who are the investors of Combinent BioMedical Systems?

    Investors of Combinent BioMedical Systems include VIMAC Ventures, Partners Innovation Fund, Commons Capital, Cytyc Development Company and Qualifying Therapeutic Discovery Project.

  • Who are Combinent BioMedical Systems's competitors?

    Competitors of Combinent BioMedical Systems include Zogenix, Omthera Pharmaceuticals, Supernus Pharmaceuticals, SupplyScape, Piedmont Pharmaceuticals and 16 more.

Compare Combinent BioMedical Systems to Competitors

A
Advent Pharmaceuticals

Advent Pharmaceuticals is a specialty pharmaceutical company focused on developing inhaled drug products using a dry powder inhalation delivery system. The products are mostly used for the treatment of asthma and other respiratory diseases.

P
Piedmont Pharmaceuticals

Piedmont is a specialty pharmaceutical company focused on human and animal health therapeutics with expertise in parasitology and drug delivery systems.

K
Kytogenics Pharmaceuticals Limited

Kytogenics is a medical device company. It had developed the Nocc Hydrophilic Wound Dressing.Kytogenics Pharmaceuticals, Inc. is a biomedical company engaged in the development of products based on its medical device and drug delivery patented platform technology.

I
IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.

C
Charleston Laboratories

Charleston Laboratories, Inc is a specialty pharmaceutical company focused on the research and development of pain products that prevent or significantly reduce nausea and vomiting, the two most burdensome side effects related to opioid analgesics and other pain associated disease states.

I
Intarcia Therapeutics

Intarcia Therapeutics is a biopharmaceutical company based in Boston, Massachusetts. Intarcia is engaged in the development of a pipeline of products for the proprietary Medici Drug Delivery System comprised of three technologies: A stabilization technology that allows for proteins, peptides, antibody fragments, and other highly potent small molecules to be stabilized at or above human body temperatures, a matchstick-sized osmotic mini-pump that is placed under the dermal layer of skin to deliver a continuous and consistent flow of medication, and a placement technology including proprietary tools designed to provide an optimal user experience.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.